Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study [0.03%]
肾上腺意外瘤和自主皮质醇分泌患者的年龄相关性和性别相关性死亡率差异：一项国际回顾性队列研究
Timo Deutschbein,Giuseppe Reimondo,Guido Di Dalmazi et al.
Timo Deutschbein et al.
Background: The association between cortisol secretion and mortality in patients with adrenal incidentalomas is controversial. We aimed to assess all-cause mortality, prevalence of comorbidities, and occurrence of cardiov...
Roger A Lobo,Anne Gompel
Roger A Lobo
Women spend approximately one-third of their lives with menopause, which occurs around 50 years of age. It is now appreciated that several important metabolic and cardiovascular disease risks emerge during the menopausal transition. Many im...
The Lancet Diabetes Endocrinology
The Lancet Diabetes Endocrinology
Rossella E Nappi,Peter Chedraui,Irene Lambrinoudaki et al.
Rossella E Nappi et al.
Menopause is often a turning point for women's health worldwide. Increasing knowledge from experimental data and clinical studies indicates that cardiometabolic changes can manifest at the menopausal transition, superimposing the effect of ...
Bruce A Perkins
Bruce A Perkins
Incidence rate patterns, cumulative incidence, and time trends for moderate and severe albuminuria in individuals diagnosed with type 1 diabetes aged 0-14 years: a population-based retrospective cohort study [0.03%]
一项基于人群的回顾性队列研究：1型糖尿病（0-14岁）患者中，中重度尿蛋白发生率、累积发病率和时间趋势模式
Fanny Jansson Sigfrids,Per-Henrik Groop,Valma Harjutsalo
Fanny Jansson Sigfrids
Background: The incidence and temporal trends of moderate and severe albuminuria during recent decades are poorly described in type 1 diabetes. We aimed to assess diabetes duration-specific incidence rates, cumulative inc...
Postsurgical radioiodine ablation in low-risk differentiated thyroid cancer [0.03%]
低风险分化型甲状腺癌的术后放射性碘清除疗法
Furio Pacini
Furio Pacini
Yong Mong Bee,E Shyong Tai,Tien Y Wong
Yong Mong Bee
Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial [0.03%]
针对2型糖尿病患者的 tirzepatide 和德谷胰岛素对肝脏脂肪含量和腹部脂肪组织的影响：一项随机、开放标签、平行组的 III 期SURPASS-3试验的子研究（SURPASS-3 MRI）
Amalia Gastaldelli,Kenneth Cusi,Laura Fernández Landó et al.
Amalia Gastaldelli et al.
Background: Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 receptor agonist under development for the treatment of type 2 diabetes. The aim of this substudy was ...
Randomized Controlled Trial
The lancet. Diabetes & endocrinology. 2022 Jun;10(6):393-406. DOI:10.1016/S2213-8587(22)00070-5 2022